Francesca Gervaso and Alessandro Polini from CNR-Nanotec have been working on multiple projects involving the creation of organ-on-a-chip systems. Recently they have published a few scientific article…
From pathobiology to synovia on chip: driving rheumatoid arthritis to the precision medicine goal
FLAMIN-GO’s VISION is to provide an organ-on-chip solution to open up a new avenue towards personalized care in RA. This solution will be based on the design and fabrication a multi-compartment microfluidic platform, for 3D culturing and perfusion, of all the disease-relevant joint tissues, focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system (vessels and leukocytes) who sustain the disease, as well as cartilage and bone which are the end damaged tissues, leading to permanent disability. The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.
In the next two days, the city of Ravena will welcome researchers working on the project FLAMIN-GO. The international research group is on a quest to develop organ-on-a-chip technology to enable a per…
Partners in the FLAMIN-GO project are proud to host a symposium during Nano Innovation 2021 Conference in Rome, from 21-24 September 2021. The event will be entitled ‘Organ-on-Chip for innovativ…
The European project FLAMIN-GO is underway within the potential of precision medicine, a breakthrough for the treatment of rheumatoid arthritis The acronym FLAMIN-GO of course calls to mind the specta…
Organ-on-chip, a multi-compartment microfluidic platform offering tailoring and personalized treatment solutions.
Focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system who sustain the disease, as well as cartilage and bone
The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.